Powerful targeted next-generation sequencing for women’s health

Testing for cervical and vaginal health currently relies on obsolete technologies that provide incomplete data, creating gaps in patient care and delays in treatment. For example, the problems of bacterial cervicitis and vaginosis are common, yet there are few diagnostic or therapeutic standards, thereby compounding these problems. Granger Genetics is dedicated to solving these problems with next-generation sequencing (NGS). NGS enables you to get more results, more quickly, in a single test.

The GynecoloGene Complete test, available exclusively from Granger Genetics, is the practical solution for diagnosis of infectious and neoplastic diseases, including bacterial vaginosis, HPV, and sexually transmitted diseases (STDs). The GynecoloGene Complete test uses DNA sequencing based on NGS methods to provide analysis of 30 targeted bacteria, fungi, and viruses along with 9 drug resistance gene markers. We believe that this represents a revolution in patient care, as this is the first use of NGS that provides a comprehensive solution.

GynecoloGene Requisition Form     GynecoloGene Flyer

GynecoloGene Testing Panel Choices

Complete BV STI
 BV Testing
 STI Testing
 Drug Resistance Markers

Different Tests

ALL bacteria, ALL parasites, ALL fungi, and targeted viruses including:
  • Bacterial Vaginosis - Associated Bacterium 1
  • Bacterial Vaginosis - Associated Bacterium 2
  • Bacterial Vaginosis - Associated Bacterium 3
  • Streptococcus agalactiae
  • Bacteroides fragilis
  • Gardnerella vaginalis
  • Mobiluncus curtisii
  • Atopobium vaginae
  • Ureaplasma urealyticum
  • Treponema pallidum
  • Enterococcus faecalis
  • Bacillus cereus
  • Mycobacterium abscessus
  • Candida albicans
  • Candida glabrata
  • Lactobacillus crispatus
  • Lactobacillus iners
  • Mycoplasma genitalium
  • Mycoplasma hominis
  • Herpes Simplex Virus Type 1
  • Herpes Simplex Virus Type 2
  • Chlamydia trachomatis
  • Neisseria gonorrhea
  • Trichomonas vaginalis